Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ziekenhuis Aan De Stroom (ZAS) is a major Belgian hospital network formed in 2024 through the merger of Ziekenhuis Netwerk Antwerpen (ZNA) and GZA Ziekenhuizen. Headquartered in Antwerp, it is one of the largest healthcare providers in Europe, employing approximately 10,000 staff members and 1,000 physicians. The network operates several specialized campuses, including ZAS Cadix, ZAS Middelheim, and ZAS Sint-Augustinus, providing a comprehensive range of medical services. ZAS offers expertise across diverse therapeutic areas such as oncology, cardiology, pediatrics, and psychiatry, serving a patient base of over one million people. The organization is committed to clinical research and innovation, frequently collaborating with academic institutions like the University of Antwerp. By integrating public and private healthcare resources, ZAS aims to optimize medical infrastructure and improve patient outcomes in the Antwerp region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ziekenhuis Aan De Stroom.